While we gather around the table on Thursday, many of us will give thanks for the blessings in our lives. Will workers’ comp be among them? In this edition of Inside Workers’ Comp, we asked industry experts Chikita Mann, Mark
More stories
Workers' Comp
Article
How Data Evolves Into Intelligent Action
Learn how connected claims data, AI and predictive analytics help claims teams identify risks earlier, improve decision-making and manage costs.
Workers' Comp
Article
AI Governance for Workers’ Compensation and Auto Insurers in 2027
Throughout 2026, lawmakers and insurance regulators have increasingly turned their attention to how artificial intelligence (AI) is governed, particularly with decisions affecting consumers. Many proposed AI bills failed to advance this year, but the volume of legislative and regulatory activity sends a clear signal that regulators expect insurers to understand, oversee, and remain accountable for AI-supported activities.
Workers' Comp
Case Study
Apricus Complex Claim Solutions
Explore how Apricus streamlined catastrophic claim care coordination for a client. See how one point of contact aligned nursing, mobility equipment and housing.
Disability
Article
Beyond Benefits: The Role of Ticket to Work in Modern Disability Programs
Discover how Genex's Ticket to Work program helps disability carriers reduce SSA-related risks, support return to work and improve claim outcomes at no added cost.
Mitchell
News Release
Mitchell Announces Plans to Transform Collision Repair Intake Through Automated Vehicle Inspection and Estimating
Mitchell today announced plans to expand its collaboration with Tractable through a proposed, exclusive agreement focused on optimizing the vehicle intake process. By connecting Tractable’s LumaScanner vehicle inspection system with Mitchell’s automated estimating solution, Mitchell Intelligent Estimating, the companies intend to help North American multi-site operators (MSOs) and independent collision repair centers accelerate damage assessment and preliminary estimate creation.
Workers' Comp
Article
Abusive Pricing and Opportunistic Categories
Pharmaceutical products classified as "opportunistic" exploit pricing gaps and regulatory variability to drive disproportionate costs with little-to-no added clinical value. While opportunistic products represent a small fraction of overall prescription volume, their financial impact is significant. This trends analysis identifies where clinical and cost interventions can have the greatest impact.